Unfortunately, PD-L1 expression by cancer cells usually inhibits the proliferation and functions of T cells in tumoral microenvironment, leading to immune suppression and impressive antitumor effects (Langhans et al., 2019; Liao et al., 2019). Here, CD274 is linked to cancer.